Pediatric osteosarcoma - treatment of the primary tumor with intravenous cis-diamminedichloroplatinum-ii (cdp) - comparison of the results with the reported efficacy of intraarterial cdp

Intravenous cis-Diamminedichloroplatinum-II (CDP) was administered to 10 patients with osteosarcoma to treat the primary tumor in 8 and bone metastases in 2. Three patients also had pulmonary metastases. The intent was to deliver 7 courses (150 mg/M2 q 2 weeks) over 3 months (total cumulative dose 1050/mg/M2). However, this was only accomplished in 2 patients; in the remaining 8 the full course was not administered because of temporary renal insufficiency (3), tumor escape (1) and apparent response after 4-6 courses suggesting that no further benefit would accrue (4). Overall, clinical and/or radiologic responses were observed in 9 patients. In 6 of 9 tumors subjected to surgical resection (66%), necrosis in excess of 65% was observed. Optimum results were achieved with a cumulative dose of 600 mg/M2 administered over 6 weeks. These results suggest that intravenous CDP may be as efficacious as intra-arterial CDP which has produced similar responses.

Medienart:

Artikel

Erscheinungsjahr:

1993

Erschienen:

1993

Enthalten in:

Zur Gesamtaufnahme - volume:3

Enthalten in:

International journal of oncology - 3(1993), 2 vom: 21. Aug., Seite 273-8

Sprache:

Englisch

Beteiligte Personen:

Jaffe, N [VerfasserIn]
Jaffe, D [VerfasserIn]
Raymond, A [VerfasserIn]
Pearson, P [VerfasserIn]
Robertson, R [VerfasserIn]
Kim, E [VerfasserIn]

Themen:

Journal Article

Anmerkungen:

Date Completed 02.10.2012

Date Revised 06.06.2019

published: Print

Citation Status PubMed-not-MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM208241337